2015
DOI: 10.1177/1060028014568008
|View full text |Cite
|
Sign up to set email alerts
|

Development of an Aggregated System for Classifying Causes of Drug-Related Problems

Abstract: An aggregated classification system was constructed through a unique and transparent developmental process that may provide the most comprehensive description of causes of DRPs to date. This may facilitate teaching of pharmaceutical care, comparisons of clinical practice, and measurement of the effectiveness of pharmaceutical care interventions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
74
0
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(77 citation statements)
references
References 120 publications
(212 reference statements)
0
74
0
3
Order By: Relevance
“…DRPs were categorized as nonadherence, overdosing or underdosing, duplication of therapy, preventable adverse drug reaction, missing medication, erroneous medication, conflicting provider information, undermonitoring or lack of monitoring, and wrong medication received. These DRPs were developed and categorized from published literature, specifically a taxonomy developed by Basger and colleagues in 2015 . There were some modifications made to this classification system given the outpatient nature of the study as well as the patient population.…”
Section: Methodsmentioning
confidence: 99%
“…DRPs were categorized as nonadherence, overdosing or underdosing, duplication of therapy, preventable adverse drug reaction, missing medication, erroneous medication, conflicting provider information, undermonitoring or lack of monitoring, and wrong medication received. These DRPs were developed and categorized from published literature, specifically a taxonomy developed by Basger and colleagues in 2015 . There were some modifications made to this classification system given the outpatient nature of the study as well as the patient population.…”
Section: Methodsmentioning
confidence: 99%
“…In Japan, home pharmaceutical care (HPC) was introduced in 1994 under the medical insurance system, and in 2000 under the long‐term care insurance system. HPC is unique in that pharmacists continually implement medicine supply and medication management for home‐bound older adults at risk of drug‐related problems who have difficulties in accessing a community pharmacy . HPC comprises the following steps a patient's doctor requests the patient's preferred community pharmacy to provide HPC the pharmacist visits the patient's home to supply medicines and carry out a medication review the pharmacist prepares a written report documenting HPC findings, which are in turn sent to the doctor and, if HPC is provided under the long‐term care insurance system, the patient's care manager.…”
Section: Introductionmentioning
confidence: 99%
“…However, since each DRPs classification system mentioned above has some defects and none of them is absolutely comprehensive, universally valid and accepted,[15] and they differ in the classification of possible DRPs, these centers cannot share data with each other. The purpose of this study is to develop and validate a comprehensive classification system for DRPs documentation for the Iranian patients.…”
Section: Introductionmentioning
confidence: 99%